Марказий Осиё эндокринологик журнали Ҷилди 4 № 2 (2024)
DIABETES MELLITUS AS AN AGGRAVATING FACTOR IN THE CLINICAL COURSE OF TUBERCULOUS SPONDYLITIS
Бабоев Абдувахоб Сахибназарович, Мирахмедова Мухаббат Пулатовна
Аннотатсия
Numerous studies have shown that active tuberculosis is detected in patients with diabetes mellitus 3-11 times more often than in the rest of the population. Currently, there are 246 million patients with diabetes mellitus in the world, about 50% of them are 30-59 years old, working and reproductive age. WHO experts predict that by 2030 this figure will be 380 million people, given the rapid growth of the population with the so-called "metabolic syndrome", overweight or obesity. Purpose of the study: to improve the effectiveness of complex antibacterial and surgical treatment of patients with complicated forms of tuberculous spondylitis and diabetes mellitus. Materials and methods of the study: 65 (35 male (53.8%) and 30 female (46.2%)) patients with tuberculous spondylitis were examined in the Department of Bone and Joint Tuberculosis of Republican Specialized Scientific and Practical Medical Center of Phthisiology and Pulmonology in 2023-2024. Mean age was 50 to 70 years. Results: Positive dynamics were observed in 44 patients after complex treatment for 8 weeks. The course of tuberculous spondylitis and the effectiveness of treatment in the groups with and without diabetes mellitus did not differ.
туберкулезный спондилит, сахарный диабет, эффективность леченияtuberculous spondylitis, diabetes mellitus, effectiveness of treatmentсил спондилит, қандли диабет, даволаш самарадорлиги
Манбаи метамаълумот: бойгонии OAI-PMH-и маҷалла · Sindex матни пурраро нигоҳ намедорад, ба манбаъ пайванд медиҳад.